Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Sep 30, 2026, 4:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–33 of 33 matching trials from the live ClinicalTrials.gov search.

Conditions: Hypertension
Interventions: Hydrochlorothiazide, Atenolol; Drug
Lead sponsor: University of Florida; Other
Eligibility: 17 Years to 65 Years
Enrollment: 1,701 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 3
States / cities: Gainesville, Florida • Atlanta, Georgia • Rochester, Minnesota

Conditions: Diabetes Mellitus, Type 2
Interventions: LY2189265, Metoprolol, Lisinopril, Placebo; Biological · Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 3
States / cities: Honolulu, Hawaii • Evansville, Indiana • Dallas, Texas

Conditions: Current or Recent History of Atrial Fibrillation
Interventions: bucindolol hydrochloride, metoprolol succinate, Placebo oral capsule; Drug · Other
Lead sponsor: ARCA Biopharma, Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 267 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 48
States / cities: Anchorage, Alaska • Phoenix, Arizona • East Palo Alto, California + 43 more

Conditions: Hypertension
Interventions: Metoprolol, Chlorthalidone; Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 65 Years
Enrollment: 839 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 3
States / cities: Gainesville, Florida • Atlanta, Georgia • Rochester, Minnesota

Conditions: Hypertension
Interventions: Metoprolol ER, Nebivolol; Drug
Lead sponsor: Forest Laboratories; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 24
States / cities: Birmingham, Alabama • Beverly Hills, California • Encinitas, California + 21 more

Conditions: Obstructive Hypertrophic Cardiomyopathy (oHCM)
Interventions: Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg), Placebo to match aficamten, Metoprolol succinate (50 mg, 100 mg, 150 mg and 200 mg), Placebo to match metoprolol succinate; Drug
Lead sponsor: Cytokinetics; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 28
States / cities: Anchorage, Alaska • Phoenix, Arizona • La Jolla, California + 21 more

Conditions: Cardiovascular Disease, Hyperlipidemia
Interventions: Evolocumab, 18F-NaF PET, CCTA, Omnipaque, Metoprolol, Nitroglycerin; Drug · Diagnostic Test
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Metoprolol succinate, Placebo; Drug · Other
Lead sponsor: University of Minnesota; Other
Eligibility: 40 Years to 84 Years
Enrollment: 532 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 27
States / cities: Birmingham, Alabama • Fresno, California • Los Angeles, California + 21 more

Search by objective public record fields.